{"id":52602,"date":"2023-01-05T20:02:13","date_gmt":"2023-01-05T19:02:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/"},"modified":"2023-01-05T20:02:13","modified_gmt":"2023-01-05T19:02:13","slug":"cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/","title":{"rendered":"Cardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women"},"content":{"rendered":"
\n

BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, today announced that researchers at Stanford Medicine selected the company\u2019s Cardea SOLO\u2122<\/a> wearable ECG system for a medical study entitled: Serial 7-Day Electrocardiogram Patch Screening for Atrial Fibrillation in High-Risk Older Women by the CHARGE-AF Score<\/a>\n<\/p>\n

<\/a><\/p>\n

\nThe study set out to measure asymptomatic atrial fibrillation (AF) in older women since AF is associated with an increased risk of stroke. The researchers wanted to determine the frequency of AF detected by serial, 7-day ECG patch screenings from patients identified as having an elevated risk of AF. The participants were mailed a Cardea SOLO ECG (electrocardiogram) patch monitor to be worn for seven days and returned for analysis.\n<\/p>\n

\nCardea SOLO is a lightweight, water-resistant ambulatory cardiac monitoring system. The wearable ECG sensor provides exceptionally accurate results using Cardia Insight\u2019s automated ECG data analysis and reporting software. Cardea SOLO\u2019s ECG detection algorithms have a 99% PPV (Positive Predictive Value) for AF detection.\n<\/p>\n

\nAnother factor that makes Cardea SOLO suited for the study is its ergonomic design. The Cardea SOLO disposable ECG biosensor has no cables and is comfortable and unobtrusive, encouraging patients to comply with prescribed wear times.\n<\/p>\n

\n\u201cWe are delighted that the research team elected to standardize on Cardea SOLO for their study,\u201d said Mr. Min Kim, Chief Executive Officer of Cardiac Insight, Inc. \u201cIn this kind of research, it\u2019s essential to have reliable, accurate results. We are proud of the sensitivity and accuracy of our wearable ECG monitoring system as we designed Cardea SOLO for in-office diagnostic procedures, so extracting patient data is easy and safe.\u201d\n<\/p>\n

\nIn addition to AF, Cardea SOLO can detect over 15 abnormal cardiac rhythms, including ventricular tachycardia, bradycardia, Premature Atrial Contractions (PACs and other potentially serious arrhythmias).\n<\/p>\n

\nFor more information, visit https:\/\/www.cardiacinsightinc.com\/cardea-solo-2<\/a>.\n<\/p>\n

\nAbout Cardiac Insight<\/b>\n<\/p>\n

\nCardiac Insight, Inc. is a leading U.S. digital healthcare innovation company specializing in the development of medical-grade, body-worn sensor technology, and automated cardiac analysis solutions through its proprietary algorithms and software platforms. The company\u2019s products include the Cardea SOLO\u2122 wearable ECG Sensor and Software Analysis System, and the Cardea 20\/20 ECG\u2122 \u2013 the only resting 12-Lead ECG System designed for cardiac risk screening in young athletes at all levels of play.\n<\/p>\n

\nFor more information, please visit:
\n
https:\/\/www.cardiacinsightinc.com\/<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMichele Nachum
\n
Firecracker PR
\n
michele@firecrackerpr.com<\/a>
425-698-7477\n<\/p>\n

\nNesli Williams
\n
Cardiac Insight, Inc.
\n
nwilliams@cardiacinsightinc.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, today announced that researchers at Stanford Medicine selected the company\u2019s Cardea SOLO\u2122 wearable ECG system for a medical study entitled: Serial 7-Day Electrocardiogram Patch Screening for Atrial Fibrillation in High-Risk … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52602","6":"format-standard","7":"category-industry"},"yoast_head":"\nCardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, today announced that researchers at Stanford Medicine selected the company\u2019s Cardea SOLO\u2122 wearable ECG system for a medical study entitled: Serial 7-Day Electrocardiogram Patch Screening for Atrial Fibrillation in High-Risk ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-05T19:02:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230105005917\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women\",\"datePublished\":\"2023-01-05T19:02:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/\"},\"wordCount\":441,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005917\\\/en\\\/1511708\\\/21\\\/Cardiac_Insight_logo_4c_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/\",\"name\":\"Cardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005917\\\/en\\\/1511708\\\/21\\\/Cardiac_Insight_logo_4c_%281%29.jpg\",\"datePublished\":\"2023-01-05T19:02:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005917\\\/en\\\/1511708\\\/21\\\/Cardiac_Insight_logo_4c_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230105005917\\\/en\\\/1511708\\\/21\\\/Cardiac_Insight_logo_4c_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/","og_locale":"en_US","og_type":"article","og_title":"Cardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women - Pharma Trend","og_description":"BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, today announced that researchers at Stanford Medicine selected the company\u2019s Cardea SOLO\u2122 wearable ECG system for a medical study entitled: Serial 7-Day Electrocardiogram Patch Screening for Atrial Fibrillation in High-Risk ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-05T19:02:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230105005917\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women","datePublished":"2023-01-05T19:02:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/"},"wordCount":441,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230105005917\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/","url":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/","name":"Cardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230105005917\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg","datePublished":"2023-01-05T19:02:13+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230105005917\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230105005917\/en\/1511708\/21\/Cardiac_Insight_logo_4c_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cardiac-insights-cardea-solo-wearable-ecg-system-chosen-for-stanford-medicine-study-to-measure-atrial-fibrillation-in-older-women\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cardiac Insight\u2019s Cardea SOLO\u2122 Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52602"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52602\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}